Basic Information
| LncRNA/CircRNA Name | RP1130-1 |
| Synonyms | LINC02055, RP1130-1 |
| Region | GRCh38_8:136530798-136984935 |
| Ensemble | ENSG00000254101 |
| Refseq | NR_147196 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | hepatocellular carcinoma |
| ICD-0-3 | C22.0 |
| Methods | qPCR etc. |
| Sample | HCC tissues, cell lines (HepG2, LO2, Huh7, and SMMC-7721) |
| Expression Pattern | down-regulated |
| Function Description | Expression of LINC RP1130-1 was found to be markedly down-regulated in 51 HCC tissues compared to matching adjacent non-tumor liver tissues. The expression of LINC RP1130-1 was associated with clinical stage, the number of tumors, portal vein tumor thrombus (PVTT), and microvascular invasion (MVI). |
| Pubmed ID | 27773892 |
| Year | 2016 |
| Title | The significance of low levels of LINC RP1130-1 expression in human hepatocellular carcinoma. |
External Links
| Links for RP1130-1 | GenBank HGNC NONCODE |
| Links for hepatocellular carcinoma | OMIM COSMIC |